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Background: Candida albicans is a diploid yeast that in some circumstances may cause oral or oropharyngeal infections.
This investigation aimed to study the prevalence of Candida spp. and to analyze the ABC genotypes of 76 clinical isolates
of C. albicans obtained from the oral cavity of kidney transplant patients from two distinct geographic regions of Brazil.
Methods: We typed 48 strains with ABC genotyping and Microsatelitte using primer M13 and tested three virulence
factors in vitro: phospholipase activity, morphogenesis and the ability to evade from polymorphonuclear neutrophils
phagocytosis.
Results: C. albicans was the most prevalent species (86.4%), followed by C. tropicalis (4.5%). C. albicans genotype A was
the most prevalent (58 isolates; 76.4%), followed by genotype C (15 isolates; 19.7%) and genotype B (3 isolates; 3.9%).
When Microsatellite technique with primer M13 was applied, 80% of the isolates from the South were placed within
the same cluster. The majority of Genotype C strains were grouped together within two different clusters. Genotype C
was considered more resistant to PMNs attack than genotypes A and B. Strains isolated from the South of Brazil
showed also better ability to combat PMNs phagocytosis.
Conclusions: We found a high rate of C. albicans genotype C strains isolated from the oral cavity of this group of
patients. This study characterized oral C. albicans strains isolated from kidney transplant recipients and will contribute
to a better understanding of the pathogenesis of oral candidiasis.
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Despite the fact that Candida spp. belong to the normal
oral microbiota, living on the tongue, gums, palate and
saliva of healthy individuals as commensal yeasts, they can
cause oral or oropharyngeal infections [1,2]. Candida spp.
have been isolated from 40 to 60% of healthy mouths,* Correspondence: guilherme.chaves@ufrnet.br
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stated.whereas oral candidiasis is more common in immunodefi-
cient individuals, those with severe underlying diseases,
and upper denture wearers [3,4].
Despite the fact that other less virulent Candida species
such as C. glabrata, C. tropicalis, C. parapsilosis, C. krusei
and C. dubliniensis have also been isolated from the saliva
of patients with or without oral candidiasis, C. albicans
is still the most frequent species associated with oral
lesions [5].
Several factors may contribute for the transition from
commensal yeasts to pathogenic forms which are related
to impaired host immune system associated with the
virulence of the micro-organism. The main virulence
factors of C. albicans include bud-to-hypha transitionentral Ltd. This is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly credited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Table 1 Demographic data of kidney transplant
recipients from Natal, RN and Maringa, PR, Brazil,
according to gender, age, and underlying disease
Variables Natal (n,%) Maringa (n,%) Total (n,%)
Sex
Male 64 (73.6) 23 (26.4) 87 (100)
Female 47 (70.1) 20 (29.9) 67 (100)
Age
12-18 years old 6 (85.7) 1 (14.3) 7 (100)
19-34 years old 44 (81.5) 10 (18.5) 54 (100)
35-64 years old 59 (64.8) 32 (35.5) 91 (100)
65 years old or more 2 (100) 0 (0) 2 (100)
Underlying disease
Diabetic nephropathy 8 (66.7) 4 (33.3) 12 (100)
Arterial hypertension 47 (85.4) 8 (14.6) 55 (100)
Glomerulonephritis 23 (76.7) 7 (23.3) 30 (100)
Polycystic kidney diseases 6 (66.7) 3 (33.3) 9 (100)
Other 27 (56.25) 21 (43.75) 48 (100)
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and endothelial cells, biofilm formation, the ability to
secrete hydrolytic enzymes (mainly proteinases and
phospholipases), phenotypic switching (white-opaque
transition) as well as evasion of host immune cells [6,7].
Some studies have evaluated C. albicans ABC genotypes
isolated from the oral cavity of different individuals and
the results seem to be very variable, according to the
population evaluated. For instance, a study with 11 dia-
betic patients with periodontitis revealed that 51.6%
subgingival C. albicans isolates belonged to genotype B
[8], while other investigation has found genotype A as
predominant [9].
The prevalence of oral candidiasis in renal transplant
recipients described in the literature ranges from 9.4%
to 46.7% [10-12]. A study performed in Mexico by De
La Rosa-Garcia et al [11], reports 18.7% of cases of
oral candidiasis in a total of 90 kidney transplanted
recipients.
Our group has previously published a comparison of
some virulence factors (biofilm production, adhesion to
human buccal epithelial cells and proteinase activity)
among C. albicans and non-C. albicans Candida isolates
obtained from the oral cavity of kidney transplant re-
cipients from Natal, Rio Grande do Norte, Brazil [13].
This study is a follow up of this previous publication
including other strains belonging to another geographic
region of Brazil. In addition, other virulence attributes
were investigated. Therefore, the objectives of the present
study were to determine Candida species distribution and
to genotypically characterize 48 C. albicans strains isolated
from the buccal cavity of 154 kidney transplanted re-
cipients from two different geographic regions of Brazil
(Northeast and South). In addition, the strains were
phenotypically characterized for the ability to express
the following virulence factors in vitro: The secretion
of phospholipase, the transition from yeast cells to hyphae




During a 3 months-period, 154 patients from two different
geographic regions of Brazil (111 from Natal, Rio Grande
do Norte and 43 from Maringa, Parana) were subjected to
clinical examination of the oral cavity for candidiasis diag-
nosis, according to the criteria established for oral lesions
in HIV patients recommended by the EC-Clearinghouse
and World Health Organization classifications [14]. Only
patients who agreed to take part on a surveillance confi-
dential study, in accordance to the Local Research Ethics
committee from The Onofre Lopes University Hospital,
approved under the number 152/07, were enrolled in
this study. Strains isolates from oral colonization (withoutany symptoms) or during episodes of oral candidiasis
were evaluated in this study. For genotyping and viru-
lence studies, we randomly selected 48 clinical strains
of C. albicans (38 from Natal, Rio Grande do Norte and
10 from Maringa, Parana). All the isolates are described
in Table 1. The samples were stocked on YPD glycerol
(10 g/L yeast extract, 20 g/L peptone, 20 g/L dextrose
and 3% glycerol) at -80°C at the Laboratório de Micologia
Médica e Molecular, Universidade Federal do Rio Grande
do Norte, Brazil. C. albicans ATCC90028 and SC5314
were included in this study as reference strains.Samples collection and yeasts identification
Samples containing 2 mL of saliva were collected from
all patients, by previous stimulation with chewing gums.
When lesions were present, a sterile swab was rubbed on
the mucosal surface of the buccal cavity. Subsequently,
100 μL of cells suspensions were inoculated on the surface
of Sabouraud Dextrose Agar (SDA; Oxoid, UK) added
300 μg/mL of cloramphenicol (Park-Davis), by using a
Drigalsky loop. The plates were incubated at 37°C for
48 h. Yeast colonies were plated on CHROMagar Candida®
(CHROMagar Microbiology, Paris, France) to check for
purity and screening for different color colonies. Species
identification was based on the characteristics of the
cells observed microscopically after cultivation on cornmeal
agar added Tween 80, as well as assimilation and fermenta-
tion testing and ID32C System (bioMérieux Marcy l’Etoile,
France), whenever it was necessary [15]. Strains belonging
to the Candida parapsilosis species complex were identified
previously with molecular methods [13].
da Silva-Rocha et al. BMC Oral Health 2014, 14:20 Page 3 of 9
http://www.biomedcentral.com/1472-6831/14/20C. albicans DNA extraction
C. albicans cells were grown overnight in YPD liquid
medium (Dextrose 20 g/L, peptone 20 g/L, Yeast Extract
10 g/L) incubated at 30°C rotated at 200 rpm in a gyratory
shaker (TE-420, Tecnal ® Piracicaba, Brazil). DNA was
extracted using the PrepMan Ultra sample preparation
reagent (Applied Biosystems, Foster City, CA) accord-
ing to the manufacturer's instructions. Genomic DNA
concentration and purity were checked with a NanoDrop
instrument (Thermo Scientific; Amersham Pharmacia
Biotech, Wilmington, DE, USA).
Microsatellite typing PCR and ABC genotyping
Microsatellite typing was performed using the primer
M13 (5’ GAGGGTGGCGGTTCT–3’) (IDT) as previously
described [16]. ABC genotyping was performed with the
following primers: CAINT- L (5′-ATAAGGGAAGTCGG-
CAAAATAGATCCGTAA-3′) and CA-INT-R (5′-CCTTG
GCTGTGGTTTCGCTAGATAGTAGAT-3′) [17]. Briefly,
1.0 μL of DNA 40 ng/μL was added to 29 PCR Master Mix
(Promega) to a final volume of 25 μL. The samples were
amplified in a Thermocycler (Amplitherm TX96, USA)
using the following cycling parameters: one initial cycle
of 94°C for 3 min followed by 30 cycles of 1 min at 94°C,
1 min at 57°C, 1 min at 72°C and a final cycle of 5 min
at 72°C. For Microsatellite typing, 1.0 μL of DNA
40 ng/μL, 2.5 μL of 10 × PCR buffer (100 mM Tris–HCl,
pH 8.3, 500 mM KCl, 3.5 mM MgCl2), 5 μL of dNTPmix
(100 mM each dNTP), 1.0 μL of each primer (50 pmol/
μL), 0.13 μL of tween 20 and 1.0 unit of Taq DNA poly-
merase were added to a final volume of 25 μL. Forty-five
cycles of amplification were performed using the same
cycling parameters described previously, except that the
annealing temperature was 36°C for the Microsatellite
typing. PCR products were size-separated by agarose
gel electrophoresis, and the gel was stained in a 0.5 μg/
mL ethidium bromide buffer solution (TAE).
Computer-assisted Microsatellite data analysis
Gel images were analyzed with the GelCompar II software,
version 4.5 and BioNumerics (Applied Maths, Kortrijk,
Belgium). The similarities between the profiles were calcu-
lated using the Dice coefficient to generate the matrixes of
similarity coefficients to dendrogram constructions. For
profile clustering, the unweighted pair-group method with
arithmetic averages was used with a tolerance of 2%.
Tests for hyphae formation
An initial amount of 106 cells/mL in YPD + 20% FBS
(Fetal Bovine Serum, Sigma-Aldrich®, Brazil) was incu-
bated at 37°C, with gyratory shaking at 200 rpm. After
3 h incubation, samples of the cultures were mixed with
an equal volume of 10% formaldehyde to arrest further
development and the mean morphology index (MI) wasdetermined [18]. Values close to 1 indicate a population
of spheroidal yeast cells and values close to 4 indicate a
population of true hyphal cells, with values between 1
and 4 indicating mixed or pseudohyphal morphologies.
Phospholipase assay
Phospholipase activity was estimated by the egg yolk
agar method [19], with inocula prepared from overnight
NGY (Neopeptone (Difco, Detroit, MI) 1 g/L, glucose
4 g/L and yeast extract 1 g/L) cultures standardized to
2 × 105 cells/mL.
Candida albicans killing by polymorphonuclear neutrophils
PMN freshly isolated from blood samples of a single
healthy volunteer on the day of the experiment [20] were
suspended in Eagle’s minimal essential medium (Gibco) +
20 mM HEPES, pH 7.2, and standardized to 8 × 105
PMN/mL. C. albicans cells grown overnight in NGY
washed and resuspended at 5 × 106 yeasts/mL in HEPES-
buffered Eagle’s minimal essential medium containing
one-tenth volume of fresh human plasma. Equal volumes
of PMN and yeast suspensions were mixed and incubated
at 37°C for 3 h with rotation at 50 rpm. The phagocytosis
of C. albicans were established by counting in triplicate
the number of yeasts inside or attached in 100 PMNs [21].
Statistical analysis
Data were analyzed using the statistical software “Graph-
Pad”, version 3.0. Results were presented as mean ±
standard deviation, and differences were analyzed by the
Mann–Whitney test. For all the analyses, P was consid-




Patient’s clinical and demographic data are summarized
in Table 1. For both regions, the majority of the patients
had arterial hypertension as the most frequent underlying
disease. In addition, the most frequent age class was 35 to
64 years old (Table 1).
Microbiology profiling of Candida spp. in oral candidiasis
From the strains obtained from Natal, RN (Northeast), it
was possible to isolate yeasts from 70 out of 111 patients
(63.1%), while from Maringa, 12 out of 43 (27.5%) Can-
dida spp positive cultures were obtained. Species distribu-
tion for both regions is described in Table 2. C. albicans
was the most predominant species found in both cities,
followed by C. tropicalis. In only a single patient from
Maringa it was possible to isolate three strains belonging
to different Candida species (C. albicans, C. glabrata,
C. tropicalis).
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lected, except for three different patients from the South
region of Brazil. From patient 37, strain 06S was obtained
from saliva, while strain 06 L from oral lesion. Patient 38
had two C. albicans strains collected from the same lesion,
showing two clear different phenotypes (10S, smooth and
10R, with rough colonies). Patient 40 showed two different
lesions and two strains were obtained, one from the tongue
and another one from the gums (15 T and 15G, respect-
ively) in addition to a strain obtained from saliva (15S).
ABC typing of Candida albicans
DNA from all the 76 strains of C. albicans and the refer-
ence strains ATCC90028 and SC5314 was submitted to
ABC typing. Genotype A was the most prevalent with
58 isolates (76.4%) followed by Genotype C, with 15
strains (19.27%) and Genotype B, with 3 isolates (3.9%;
Table 3). The same trend was observed when the strains
obtained from each region were analyzed separately: In
the Northeast of Brazil, C. albicans genotype A was the
most prevalent, with 42 isolates (71.2%), followed by
Genotype C (n = 14 isolates; 23.7%) and Genotype B, with
3 strains (5.1%). The higher incidence of genotype A was
also found in the South of the country with 16 isolates
(94.1%) followed by genotype C (n = 1 isolate; 5.9%). C.
albicans genotype B was not observed for the isolates
obtained from this region (Table 3).
Candida albicans microsatellite typing versus
ABC genotyping
We randomly selected 48 isolates of C. albicans including
some strains belonging to genotype A (21 from Natal and
10 from Maringa) an all the other strains belonging to
genotypes B and C from both regions and performed
Microsatellite genotyping. The genomic DNA of all of
the 48 isolates was successfully amplified with the M13
primer, which targets genome repetitive sequences. The
DNA amplification generated well-defined band patterns,
ranging from 100 pb to 2 kb. The microsatellite technique
showed sufficient discriminatory power for recognizing
intraspecific variation (Figure 1). As expected, the externalTable 2 Species distribution of Candida spp. isolated of oral
cavity of kidney transplant recipients from two different
geographic regions of Brazil: Natal, RN and Maringa, PR
Species Natal (n,%) Maringá (n,%) Total (n,%)
Candida albicans 59 (77.6) 17 (22.4) 76 (100)
Candida dubliniensis 2 (100) 0 (0) 2 (100)
Candida glabrata 2 (66.7) 1 (33.3) 3 (100)
Candida tropicalis 3 (75) 1 (25) 4 (100)
Candida orthopsilosis 2 (100) 0 (0) 2 (100)
Candida metapsilosis 2 (100) 0 (0) 2 (100)
Total 69 (78.4) 19 (21.6) 88 (100)control strains of C. albicans, SC5314 and ATCC90028,
were placed in completely different clusters by the dendro-
gram analysis performed using GelCompar II, proving the
efficiency of the technique in separating strains isolated
from different geographic areas. These control strains
showed 75% similarity and were placed together within a
different cluster of all the other clinical isolates (Figure 1).
We could not detect any particular cluster of either
colonizing or infecting strains. In addition, in both cases,
strains with 100% similarity obtained from different
patients were found. Regarding to the comparisons of
genetic relatedness within the two different geographic
regions of Brazil, we could observe an enriched cluster
for Maringa (South), where 80% of the strains were
placed together. In addition, they ranged from 80% up
to 93% similarity among them.
Other interesting finding is associated with some
degree of correlation observed between the ABC type
of C. albicans and the high percentage of similarity
among these isolates when Microsatellite primer M13
was used. In most of the cases, strains with identical
percentage of similarity determined with primer M13,
also had the same A or C genotype (except for strains
02 and 85 from Natal as well as 15 T and 18A from
Maringa; A and C genotypes in both cases). In addition,
C. albicans genotype C strains from Natal were placed
within two well-defined separated clusters with proven
high relatedness (more than 90% similarity within the
same cluster). In relation to genotype B, two out of
three isolates showed a similarity of 94%, being placed
in the same cluster (Figure 1).
Furthermore, when different strains were obtained from
different samples of the same patient, they all had the
same ABC genotype (genotype A). Nevertheless, Microsat-
ellite using primer M13 showed higher discriminatory
power, because these strains were not considered identical
with the latest technique, showing some degree of genetic
variability, when this method was used.Virulence attributes of Candida albicans A, B and C
genotypes
For all the virulence factors tested, we only performed
statistical analysis for comparisons among strains belong-
ing to genotypes A and C, because of the low number
of isolates belonging to genotype B found. In relation
to phospholipase production, all the strains were able
to produce the enzyme, regardless if they were obtained
from episodes of colonization or infection. For geno-
type A, a Mean Pz of 0.51 ± 0.04 was obtained, while
for genotype C, a Mean of 0.55 ± 0.05, while for the
genotype B, the Mean Pz was 0.57 ± 0.07. No statistical
differences were found when strains belonging to geno-
types A and C were compared (Table 3).
Table 3 Patients enrolled in this study, geographic region ABC genotyping and virulence attributes of Candida albicans




No of C. albicans cells phagocytosed
by 100 PMNs* (%)
1 Colonization Natal B 0.6 ± 0.07 2.46 ± 0.70 134 ± 15.3
2 Colonization Natal A 0.55 ± 0.04 3.43 ± 0.77 115 ± 14.6
3 Colonization Natal A 0.48 ± 0.06 3.22 ± 0.64 66 ± 7.9
5 Infection Natal C 0.58 ± 0.02 2.23 ± 0.57 98 ± 6.7
6 Colonization Natal A 0.53 ± 0.01 2.24 ± 0.51 100 ± 12.5
8 Colonization Natal A 0.57 ± 0.04 1.86 ± 0.43 130 ± 19
10 Infection Natal B 0.56 ± 0.12 2.17 ± 0.62 166 ± 8.4
11 Colonization Natal C 0.58 ± 0.08 2.15 ± 0.77 28 ± 3.5
12 Infection Natal A 0.54 ± 0.02 2.46 ± 0.56 150 ± 11.1
13 Colonization Natal C 0.6 ± 0.03 2.17 ± 0.65 126 ± 31.6
17 Colonization Natal A 0.52 ± 0.03 3.63 ± 0.63 98 ± 20.2
20 Colonization Natal A 0.44 ± 0.01 2.85 ± 0.81 86 ± 21.2
21 Colonization Natal A 0.4 ± 0.06 2.78 ± 0.92 114 ± 21.5
23 Colonization Natal C 0.53 ± 0.09 2.45 ± 0.67 101 ± 11.4
24 Infection Natal A 0.51 ± 0.10 3.05 ± 0.74 132 ± 13.9
28 Infection Natal A 0.55 ± 0.04 2.84 ± 0.80 165 ± 9.5
30 Colonization Natal C 0.52 ± 0.04 2.17 ± 0.62 119 ± 20
31 Colonization Natal A 0.49 ± 0.03 2.64 ± 0.82 129 ± 15
32 Colonization Natal A 0.49 ± 0.12 2.81 ± 0.65 123 ± 13.2
34 Colonization Natal A 0.52 ± 0.07 2.36 ± 0.64 156 ± 16.5
37 Colonization Natal B 0.57 ± 0.01 3.38 ± 0.80 124 ± 19.1
40 Infection Natal A 0.51 ± 0.06 3.7 ± 0.56 142 ± 15.9
41 Colonization Natal A 0.54 ± 0.03 2.7 ± 0.69 172 ± 21.1
44 Infection Natal A 0.48 ± 0.03 2.8 ± 0.77 176 ± 11.6
46 Colonization Natal A 0.46 ± 0.04 2.81 ± 0.77 172 ± 20.1
50 Colonization Natal A 0.54 ± 0.04 3.24 ± 0.88 157 ± 36.6
51 Colonization Natal A 0.51 ± 0.02 2 ± 0.43 130 ± 19.5
53 Colonization Natal C 0.53 ± 0.09 2.79 ± 0.71 132 ± 15.9
54 Colonization Natal A 0.47 ± 0.02 1.8 ± 0.40 132 ± 9.2
60 Colonization Natal C 0.57 ± 0.03 2.15 ± 0.36 146 ± 9
61 Colonization Natal A 0.49 ± 0.01 2.48 ± 0.75 142 ± 9.2
70 Colonization Natal C 0.51 ± 0.03 2.99 ± 0.50 140 ± 12.7
72 Colonization Natal C 0.46 ± 0.04 2.31 ± 0.61 136 ± 9
82 Colonization Natal C 0.55 ± 0.03 3.36 ± 0.93 130 ± 13.2
85 Colonization Natal C 0.56 ± 0.04 3.15 ± 0.83 144 ± 9.5
107 Colonization Natal C 0.57 ± 0.01 2.39 ± 0.63 156 ± 10.1
06A Colonization Maringá A 0.5 ± 0.02 2.34 ± 0.71 80 ± 17.4
06 L Infection Maringá A 0.56 ± 0.07 2.94 ± 0.58 75 ± 8.7
10Li Colonization Maringá A 0.55 ± 0.01 2.42 ± 0.70 176 ± 6.1
10S Colonization Maringá A 0.64 ± 0.01 2.54 ± 0.76 105 ± 14.7
12A Colonization Maringá A 0.49 ± 0.02 3.3 ± 0.79 59 ± 16.8
12 L Infection Maringá A 0.51 ± 0.05 3.2 ± 0.68 90 ± 13.2
15A Colonization Maringá A 0.42 ± 0.02 2.96 ± 0.83 116 ± 27.1
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Table 3 Patients enrolled in this study, geographic region ABC genotyping and virulence attributes of Candida albicans
(Continued)
15G Infection Maringá A 0.42 ± 0.03 3.13 ± 0.81 86 ± 21.9
15 L Infection Maringá A 0.47 ± 0.08 2.58 ± 0.68 76 ± 16.5
18A Colonization Maringá C 0.56 ± 0.11 3.05 ± 0.67 102 ± 11.2
111 L Colonization Natal C 0.55 ± 0.03 2.6 ± 0.70 80 ± 17.4
111R Colonization Natal C 0.6 ± 0.15 4 ± 0.00 11 ± 3.2
ATCC90028 Reference A 0.7 ± 0.08 3.82 ± 0.5 158 ± 17.5
SC5314 Reference A 0.52 ± 0.04 3.28 ± 0.81 137 ± 20.6
The isolates were obtained from the oral cavity of kidney transplant recipients from Natal, RN and Maringa, PR, Brazil.
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cells morphology, no clear differences could be observed
for the three different A, B or C genotypes. The ability
of the strains to change the morphology from bud cells
to hyphae when grown in the presence of YPD + 20%
FBS was verified for strains belonging to the three
referred genotypes. Cells were predominantly found as
pseudohyphae, with a mean MI ranging from 2.66 ± 0.61
(genotype C) to 2.77 ± 0.69 (genotype A). The mean MI
isolates of genotype B was 2.67 ± 0.71. No statistical dif-
ferences were observed among the isolates (Table 3).
We also investigated the ability of the different strains
to resist to phagocytosis by PMNs. Therefore, the num-
ber of C. albicans cells phagocytosed by 100 PMNs was
determined after three hours of co-incubation of both
cells. C. albicans genotype C was more resistant to PMNs
attack. Strains belonging to genotype B had an average of
141.33 ± 14.27 cells phagocytosed by 100 PMNs. Strains
belonging to genotype C were significantly more resistant
to the attack of phagocytic cells than the isolates be-
longing to genotype A (Mean of 109.93 ± 12.29 versus
121.67 ± 16.06, respectively; Table 3).
Virulence attributes of Candida albicans strains ob-
tained from two different geographic regions of Brazil
(Northeast and South).
When the pathogenicity factors were compared among
all the strains obtained from the two geographic regions,
the strains obtained from Maringa (South) expressed more
efficiently all the virulence factors evaluated in vitro. This
difference was considered statistically significant for resist-
ance to phagocytosis by PMN (Table 4). Interestingly, 40%
of the isolates obtained from Maringa were obtained from
lesions, whereas only 18.4% of the isolates from Natal were
infecting (Tables 3 and 4).
Discussion
In our study including 154 patients with oral candidiasis,
the vast majority of isolates were C. albicans. This is in
accordance with other studies that although report an
increase of Non-Candida albicans Candida species, C.
albicans is still predominant [13,22-24].Because C. albicans is the most virulent and frequently
isolated species of the genus Candida from oral candid-
iasis, we phenotypically characterized three attributes of
virulence (extracellular activity of phospholipase, mor-
phogenesis and resistance to phagocytosis by PMNs) of
48 clinical isolates of this species obtained from the oral
cavity of 154 kidney transplanted patients from two
different regions of Brazil (Northeast and South). In
addition, we investigated genetic relatedness of these strains
with two different methodologies of genotyping (ABC
typing and Microsatelitte technique with M13 primer).
We found in the present study a high incidence of C.
albicans isolates belonging to genotype C from the oral cav-
ity of kidney transplant recipients. Nevertheless, C. albicans
genotype A was still the most prevalent. The majority of
other series upon oral candidiasis or oral colonization in-
vestigating C. albicans ABC genotypes with the same
method have found genotype A as the most prevalent type
[9,24,25]. C. albicans Genotype A is also predominant in
other series with strains obtained from different body sites,
including cases of systemic infection [17,26-29].
Interestingly, we found a high incidence of strains
belonging to genotype C in our study. This seems to be
an unusual finding. For instance, in the study of Sardi
et al [8], genotype C was not found. The same findings
were observed by Jacobsen et al. [30]. In a total of 32
individuals with C. albicans oral colonization, oral can-
didiasis and other superficial infections, only one strain
belonging to genotype C was found. Actually, Odds et al.
[28] described genotype C as a rare genotype, found in
only 173 isolates of 1931 C. albicans obtained from differ-
ent sources of the world. To the best of our knowledge,
this is the largest population study on C. albicans typing.
Another intriguing finding is that, except for two
cases, all the type C strains were placed together within
two well-defined separated clusters in the dendrogram.
Mccullough et al [17] hypothesized that C. albicans geno-
type C is probably genotype A that probably acquired
an intron. This may partially explain why they were
considered identical by Microsatellite technique in two
occasions. Taking together, these data suggest the peculiar-
ity of the distribution of genotypes of C. albicans isolates
Figure 1 Unweighted pair-group method with arithmetic averages dendrogram with 2% of tolerance of 50 strains of Candida albicans
clinical isolates.
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Table 4 Virulence attributes of Candida albicans isolates
obtained from the oral cavity of kidney transplant
recipients of two geographic regions of Brazil: Natal,
RN and Maringa, PR
Natal vs Maringa
Phospholipase activity PZ (cm) 0.53 ± 0.05 vs 0.51 ± 0.04
Morphology index MI 2.70 ± 0.65 vs 2.85 ± 0.72
No of C. albicans cells phagocytosed
by 100 PMNs**
125.61 ± 14.61 vs 96.50 ± 16.36*
*Statistically significant; P < 0.05. **PMNs- = polymorphonuclear neutrophils.
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analyzed in our study.
Microsatellite genotyping using primer M13 showed
satisfactory discriminatory power and may be applied for
epidemiological studies of C. albicans infection with low
cost and good effectiveness. This technique has not been
widely used for this species [21], but has been largely
used to type Cryptococcus neoformans [16,31].
The fact that we have found some strains obtained
from different patients considered undistinguishable (100%
similarity) is not unusual. Other authors have described
that it is possible that unrelated strains share the same
genotype. For instance, Sampaio et al [32] using Micro-
satellite technique with CAI4 locus found that in 73
independent vaginal isolates, 44 genotypes could be de-
tected. In addition, we could not completely rule out
the possibility of strain cross-contamination while their
staying in Hospital.
One of our remarkable findings was the placement of
most of the strains from the South of Brazil within the
same cluster. They also shared the same ABC type
(genotype A). This fact may be partially explained due
to C. albicans co-evolution with humans in determined
geographic regions once this species belongs to the
normal oral microbiota [28].
We found some degree of correspondence of strains
genetic relatedness when both genotyping methodologies
were applied. Only in two occasions, strains with different
A or C types were designated as identical with Microsatel-
lite technique. This difference reinforces the necessity
of a combination of at least two different techniques
for C. albicans strains typing [33].
Besides the fact we have found a high rate of type C
strains of C. albicans, these strains were also statistically
more resistant to phagocytosis by PMNs than genotypes A
and B strains. Although at the moment of strains collection
only one genotype C strain was obtained from patients
with lesions, the fact that they were immunosuppressed
individuals and colonized by possibly virulent strains that
were able to highly express the virulence factors evaluated
in vitro may influence future clinical outcomes.
Related to the virulence factors expressed by the isolates
from Natal and Maringa, it was possible to observe thatthe isolates from the South of Brazil were markedly resist-
ant to phagocytosis by PMNs. A recent study regarding
the characterization of oral biofilms formed on mucosal
surfaces found that a strong migration of PMNs which
formed intense nests of aggregates juxtaposed to mucosal
biofilms. In addition, in sites with thicker biofilms, neutro-
phils migrated through the entire width of the mucosa,
reinforcing the importance of specific white cells also
in oral candidiasis [34].Conclusions
A limitation of our study was the low number of isolates,
specifically belonging to genotype B. Nevertheless we
could demonstrate the peculiarities of C. albicans strains
obtained from the oral cavity of kidney transplant recipi-
ents of two different regions of Brazil. Considering that
this country has continental dimensions, we found that
most of the strains of each different region were placed
in the same cluster and were markedly resistant to
phagocytosis by PMNs. In addition, we also found a high
rate of genotype C (a rare genotype) strains isolated from
the oral cavity of this group of patients. To the best of our
knowledge, this study is the first one to characterize oral
C. albicans strains of kidney transplant recipients from
two different regions of a continental size country (Brazil).
Abbreviations
C: Candida; spp: Species; PMN: Polymorphonuclear; YPD: Yeast peptone
dextrose; g/L: Grams per liter; °C: Celsius degrees; ATCC: American Type
Culture Collection; SDA: Sabouraud dextrose agar; UK: United Kingdom;
μg/mL: Micrograms per milliliter; h: Hour; DNA: Deoxyribonucleic acid;
rpm: Revolutions per minute; CA: California; DE: Delaware; USA: United States
of America; PCR: Polymerase chain reaction; G: Guanine; A: Adenine;
C: Cytosine; T: Thymine; IDT: Integrated DNA technologies; μL: Microliter;
ng/μL: Nanograms per microliter; mM: Millimolar; HCl: Chloridric acid;
pH: Potencial hydrogen; KCl: Potassium chloride; MgCl2: Magnesium chloride;
dNTP: pmol/μL, picomoles per microliter; FCS: Fetal calf serum;
MI: Morphology index; NGY: Cells/ml. cells per microliter; HEPES: PMN/mL,
polymorphonuclear per microliter; bp: Base pairs; Pz: Phospholipase zone.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
WP and GM analyzed data, performed research; wrote the paper. VL
permormed research, TI and EP, collected samples. All authors read and
approve the final manuscript.
Authors’ information
GM, Professor of Clinical Microbiology, Dept. de Análises Clínicas e
Toxicológicas, Universidade Federal do Rio Grande do Norte, Brazil and
Leader of the Laboratório de Micologia Médica e Molecular.
Acknowledgements
We are very grateful to the Conselho Nacional de Desenvolvimento
Científico e Tecnológico (CNPq) grant Edital Universal 14/2011 and to the
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
grant PROCAD CAPES NF-2008 for financial support. We also would like to
thank Prof. Arnaldo Lopes Colombo for the donation of control strains and
support with dendrogram analysis.
da Silva-Rocha et al. BMC Oral Health 2014, 14:20 Page 9 of 9
http://www.biomedcentral.com/1472-6831/14/20Author details
1Laboratório de Micologia Médica e Molecular, Departamento de Análises
Clínicas e Toxicológicas, Universidade Federal do Rio Grande do Norte, Natal,
Rio Grande do Norte, Brazil. 2Departamento de Infectologia, Universidade
Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.
3Departamento de Análises Clínicas, Universidade Estadual de Maringá,
Maringá, Paraná, Brazil. 4Universidade Federal do Rio Grande do Norte,
Centro de Ciências da Saúde, Departamento de Análises Clínicas e
Toxicológicas, Laboratório de Micologia Médica e Molecular. Rua Gal.
Gustavo Cordeiro de Faria S/N. Petrópolis, Natal, Rio Grande do Norte, Brazil.
Received: 14 September 2013 Accepted: 5 March 2014
Published: 15 March 2014
References
1. Lortholary O, Petrikkos G, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M,
Bille J, Calandra T, Castagnola E, Cornely OA, Cuenca-Estrella M, Donnelly JP,
Garbino J, Groll AH, Herbrecht R, Hope WW, Jensen HE, Kullberg BJ, Lass-Flörl C,
Meersseman W, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ,
ESCMID Fungal Infection Study Group: ESCMID guideline for the diagnosis
and management of Candida diseases 2012: patients with HIV infection or
AIDS. Clin Microbiol and Infect 2012, 18:68–77.
2. Patel PK, Erlandsen JE, Kirkpatrick WR, Berg DK, Westbrook SD, Louden C,
Cornell JE, Thompson GR, Vallor AC, Wickes BL, Wiederhold NP, Redding SW,
Patterson TF: The changing epidemiology of oropharyngeal Candidiasis
in patients with HIV/AIDS in the era of antiretroviral therapy. AIDS Res
Treat 2012, 2012:262471.
3. Milan EP, Kallás EG, Costa PR, Da M, DA Colombo AL: Oral colonization by
Candida spp. among AIDS household contacts. Mycoses 2001, 44:273–277.
4. Lalla RV, Latortue MC, Hong CH, Ariyawardana A, D'Amato-Palumbo S,
Fischer DJ, Martof A, Nicolatou-Galitis O, Patton LL, Elting LS, Spijkervet FK,
Brennan MT, Fungal Infections Section, Oral Care Study Group, Multinational
Association of Supportive Care in Cancer (MASCC)/International Society of
Oral Oncology (ISOO): A systematic review of oral fungal infections in
patients receiving cancer therapy. Support Care Cancer 2010, 18:985–992.
5. Oliveira MA, Carvalho LP, Gomes MS, Bacellar O, Barros TF, Carvalho EM:
Microbiological and immunological features of oral candidiasis. Microbiol
Immunol 2007, 51:713–719.
6. Calderone RA: Candida and Candidiasis. ASM Press; 2011:544.
7. Mayer FL, Wilson D, Hube B: Candida albicans pathogenicity mechanisms.
Virulence 2013, 9:119–128.
8. Sardi JC, Duque C, Höfling JF, Gonçalves RB: Genetic and phenotypic
evaluation of Candida albicans strains isolated from subgingival biofilm of
diabetic patients with chronic periodontitis. Med Mycol 2012, 50:467–475.
9. McManus BA, Maguire R, Cashin PJ, Claffey N, Flint S, Abdulrahim MH,
Coleman DC: Enrichment of multilocus sequence typing clade 1 with oral
Candida albicans isolates in patients with untreated periodontitis. J Clin
Microbiol 2012, 50:3335–3344.
10. Al-Mohaya MA, Azmi D, Al-Khudair W: Oral fungal colonization and oral
candidiasis in renal transplant patients: the relationship to Miswak use.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002, 93:455–460.
11. de la Rosa-García E, Mondragón-Padilla A, Irigoyen-Camacho ME,
Bustamante-Ramírez MA: Oral lesions in a group of kidney transplant
patients. Med Oral Patol Oral Cir Bucal 2005, 10:196–204.
12. Güleç AT, Demirbilek M, Seçkin D, Can F, Saray Y, Sarifakioglu E, Haberal M:
Superficial fungal infections in 102 renal transplant recipients:
a case–control study. J Am Acad Dermatol 2003, 49:187–192.
13. Chaves GM, Diniz MG, da Silva-Rocha WP, de Souza LB, Gondim LA, Ferreira
MA: Species distribution and virulence factors of Candida spp. isolated from
the oral cavity of kidney transplant recipients in Brazil. Mycopathologia 2013,
175:255–263.
14. Classification and diagnostic criteria for oral lesions in HIV infection: EC-
clearinghouse on oral problems related to HIV infection and WHO
collaborating centre on oral manifestations of the immunodeficiency
virus. J Oral Pathol Med 1993, 22:91–289.
15. Alves SH, Milan EP, de Laet Sant'Ana P, Oliveira LO, Santurio JM, Colombo
AL: Hypertonic sabouraud broth as a simple and powerful test for
Candida dubliniensis screening. Diagn Microbiol Infect Dis 2002, 43:85–86.
16. Casali AK, Goulart L, Rosa e Silva LK: Molecular typing of clinical and
environmental Cryptococcus neoformans isolates in the Brazilian state Rio
Grande do Sul. FEMS Yeast Res 2003, 3:405–415.17. McCullough MJ, Clemons KV, Stevens DA: Molecular and phenotypic
characterization of genotypic Candida albicans subgroups and
comparison with Candida dubliniensis and Candida stellatoidea. J Clin
Microbiol 1999, 37:417–421.
18. Merson-Davies LA, Odds FC: A morphology index for characterization of
cell shape in Candida albicans. J Gen Microbiol 1989, 135:3143–3152.
19. Price MF, Wilkinson ID, Gentry LO: Plate method for detection of
phospholipase activity in Candida albicans. Sabouraudia 1982, 20:7–14.
20. Fradin CP, De Groot P, Maccallum D, Schaller M, Klis F, Odds FC, Hube B:
Granulocytes govern the transcriptional response, morphology and
proliferation of Candida albicans in human blood. Mol Microbiol 2005,
56:397–415.
21. Chaves GM, Silva WP: Superoxide dismutases and glutaredoxins have a
distinct role in the response of Candida albicans to oxidative stress
generated by the chemical compounds menadione and diamide.
Mem Inst Oswaldo Cruz 2012([online]):107.
22. Anees MM, Reich A, Hirschberg L, Watorek E, El-Shinnawi UM, Ibrahiem TM,
El-Shaarawy S, Szepietowski JC: Enhanced enzymatic activit of Candida
species responsible for oral candidiasis in renal transplant recipients.
Mycoses 2011, 54:337–344.
23. Zahir RA, Himratul-Aznita WH: Distribution of Candida I the oral cavity and
its differentiation based on the internall transcribed spacer (ITS) regions
of rDNA. Yeast 2013, 30:13–23.
24. Takagi Y, Fukano H, Shimozato K, Tanaka R, Horii T, Kawamoto F, Kanbe T:
Genotypes of Candida albicans isolated from healthy individuals and
their distribution in patients with oral candidiasis. J Infect Chemother
2013, [Epub ahead of print].
25. Odds FC, Jacobsen MD: Multilocus sequence typing of pathogenic
Candida species. Eukaryot Cell 2008, 7:1075–1084.
26. Da Matta DA, Melo AS, Guimarães T, Frade JP, Lott TJ, Colombo AL: Multilocus
sequence typing of sequential Candida albicans isolates from patients with
persistent or recurrent fungemia. Med Mycol 2010, 48:757–762.
27. Odds FC, Davidson AD, Jacobsen MD, Tavanti A, Whyte JA, Kibbler CC, Ellis DH,
Maiden MC, Shaw DJ, Gow NA: Candida albicans strain maintenance,
replacement, and microvariation demonstrated by multilocus sequence
typing. J Clin Microbiol 2006, 44:3647–3658.
28. Odds FC, Bougnoux ME, Shaw DJ, Bain JM, Davidson AD, Diogo D, Jacobsen MD,
Lecomte M, Li SY, Tavanti A, Maiden MC, Gow NA, d'Enfert C:Molecular
phylogenetics of Candida albicans. Eukaryot Cell 2007, 6:1041–1052.
29. Chaves GM, Santos FP, Colombo AL: The persistence of multifocal
colonisation by a single ABC genotype of Candida albicans may predict
the transition from commensalism to infection. Mem Inst Oswaldo Cruz
2012, 07:198–204.
30. Jacobsen MD, Duncan AD, Bain J, Johnson EM, Naglik JR, Shaw DJ, Gow NA,
Odds FC: Mixed Candida albicans strain populations in colonized and
infected mucosal tissues. FEMS Yeast Res 2008, 8:1334–1338.
31. Ferreira-Paim K, Andrade-Silva L, Mora DJ, Pedrosa AL, Rodrigues V, Silva-Vergara
ML: Genotyping of Cryptococcus neoformans isolated from captive birds in
Uberaba, Minas Gerais, Brazil. Mycoses 2011, 54:e294–e300.
32. Sampaio P, Gusmão L, Alves C, Pina-Vaz C, Amorim A, Pais C: Highly
polymorphic microsatellite for identification of Candida albicans Strains.
J Clin Microbiol 2003, 41:552–557.
33. Soll DR: The ins and outs of DNA fingerprinting the infectious fungi.
Clin Microbiol Rev 2000, 13:332–370.
34. Dongari-Bagtzoglou A, Kashleva H, Dwivedi P, Diaz P, Vasilakos J:
Characterization of mucosal Candida albicans biofilms. PLoS ONE 2009,
4:e7967.
doi:10.1186/1472-6831-14-20
Cite this article as: da Silva-Rocha et al.: Candida species distribution,
genotyping and virulence factors of Candida albicans isolated from the oral
cavity of kidney transplant recipients of two geographic regions of Brazil.
BMC Oral Health 2014 14:20.
